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1The Voice of the Editor-in-Chief
Traditionally, at the beginning of the new year 
I would like to summarize the year that has passed 
and first of all thank you for the active participation 
in creating our journal by submitting many interesting 
papers to “Clinical Diabetology”. At the same time, 
I would like to emphasize that it has been two years 
since we started publishing our journal entirely in 
English. Moreover, increased proportion of original 
papers and case reports received by the Editorial Of-
fice have been submitted by foreign authors, which 
significantly broadens our view on diabetes care and 
improves the rank of “Clinical Diabetology”. The ma-
nuscripts sent by you, both review and original articles 
as well as case reports, deal with all aspects of diabetes 
management and their content is useful in everyday 
practice. Last year we also discussed many difficult, 
sometimes neglected, topics related to carbohydrate 
metabolism disorders, for example, those concerning 
sexual dysfunction, risk of cancer in relation to anti-
diabetic drugs, the role of dietary intervention in the 
treatment of gestational diabetes and primary and 
secondary prevention of type 2 diabetes.
I am happy to present to you the last issue of 
“Clinical Diabetology” in 2017. I would like to draw 
your attention to the problem of diabetes care quality 
discussed by researchers from Libya, an interesting case 
report of the use of hydroxychloroquine in type 2 dia-
betes refractory to treatment with more than two oral 
hypoglycaemic drugs, and rare complications after the 
use of sitagliptin presented by the authors from India. 
Worth reading are also articles about the management 
of diabetic foot syndrome.
Summing up, I would like to emphasize again that 
the success of the “Clinical Diabetology” journal is pri-
marily your merit and I look forward to further fruitful 
cooperation with you in creating the journal of ever 
higher scientific quality and practical value. Evidence 
of its growing importance is the fact that the Editorial 
Board, with the significant support of the General Board 
of the Diabetes Poland and the Publisher, decided to 
apply for “Clinical Diabetology” to be listed in other 
databases, first ESCI (Emerging Sources Citation Index) 
being a part of the Web of Science Core Collection and 
Pubmed Central.
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